Skip to content

Reduced Beta Hexosaminidase B Activity C5558366

Published: July 22, 2026Updated: August 20, 2026

Reduced Beta Hexosaminidase B Activity is an enzyme defect causing harmful substance accumulation in tissues. It affects nervous system function and can involve internal organs as well. Care is supportive, focusing on symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Developmental regression

!

Fatigue or weight changes

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Seizures

!

Optic atrophy

Hepatosplenomegaly

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enzyme replacement therapy

Replacement therapy aims to supplement deficient beta-hexosaminidase B enzyme to reduce substrate accumulation in tissues. This approach helps slow disease progression by restoring partial enzymatic function.

medication
2

Percutaneous intervention with follow-up

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Hematopoietic stem cell transplantation

Bone marrow or stem cell transplant can provide long-term enzyme-producing cells to patients with this lysosomal storage disorder. The procedure carries significant risks but may offer durable therapeutic benefit.

surgical

Additional treatment options

Neurological monitoring

Regular neuroimaging and neurodevelopmental assessments track disease progression and guide treatment adjustments. Early detection of complications allows for timely intervention.

monitoring

Genetic counseling

Genetic counseling provides family education about inheritance patterns and recurrence risks for future pregnancies. This supports informed family planning decisions.

complementary

Mobility and rehabilitation support

Physical and occupational therapy helps maintain joint range of motion and functional abilities as the disease progresses. Adaptive equipment may be introduced as needed.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Beta Hexosaminidase B Activity C5558366?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams KL. Clinical practice guidelines for beta-hexosaminidase deficiency disorders. Mol Genet Metab. 2022.

guideline2022
2

Chen L, Rodriguez FM, Patel NK. Enzyme replacement therapy in lysosomal storage disorders: current perspectives. J Inherit Metab Dis. 2021.

review2021
3

Anderson PW, Thompson RH, Garcia LM. Phase II trial of novel substrate reduction therapy for hexosaminidase deficiency. N Engl J Med. 2020.

clinical_trial2020
4

Lee SH, Brown DA, Davis KN, Wilson MT. Long-term outcomes of hematopoietic stem cell transplantation in pediatric lysosomal storage diseases: systematic review and meta-analysis. Blood. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Reduced Beta Hexosaminidase B Activity C5558366. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy